Transposition of the great vessels screening: Difference between revisions
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Cardiology]] | |||
[[Category:Congenital heart disease]] | |||
[[Category:Genetic Disease]] | |||
[[Category:Disease]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 13:58, 12 October 2012
Transposition of the great vessels Microchapters |
Classification |
---|
Differentiating Transposition of the great vessels from other Diseases |
Diagnosis |
Treatment |
Surgery |
Case Studies |
Transposition of the great vessels screening On the Web |
American Roentgen Ray Society Images of Transposition of the great vessels screening |
Risk calculators and risk factors for Transposition of the great vessels screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]
Overview
Screening
Most of the time, diagnosis can be doned after 18 weeks gestation using an ultrasound. However, if it is not diagnosed in utero, cyanosis of the newborn (blue baby) should immediately indicate that there is a problem with the cardiovascular system. Screening could be done by echocardiography